Sanofi Aventis recently announced that a US Court has ordered the seizure of Frontline Plus, a drug produced by Cipla and sold by Velecra. On the back of this, the share price of Cipla has fallen around 1.5%.
first published: Jun 30, 2011 12:55 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
Live: RBI Policy Expectations| Rupee Slide, Strong GDP & Soft Inflation – Will MPC Cut Or Pause?
Nifty Holds Key Support; Volatile Trade Likely on Sensex Expiry | Opening Bell Live
Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live
